Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
冻干 · 5 mg / vial
Growth & Anabolic
5 mg / vial
Tesamorelin 5mg — Stabilized GHRH(1-44) Analog
N-terminal hexenoyl modification · Extended action · DPP-4-resistant GHRH
Premium Grade
Out of Stock
Stabilized analog of human GHRH(1-44) with N-terminal hexenoyl modification — extended action.
- CAS 编号
- 218949-48-5
- 分子量
- 5 135.85 Da
- 纯度
- ≥ 99.0% (HPLC)
- 储存
- −20 °C，冻干
氨基酸序列
trans-3-hexenoyl-GHRH(1-44)-NH2
订单满 $59 免费$7.99 美国境内（48小时）· $14.99 全球（5个工作日）
低调包装普通隔热邮袋，外包装不显示化合物名称。
分析证书
每批次分析报告 — HPLC、ESI-MS、LAL 内毒素检测、重金属、无菌性
当前批次TES661
已放行2026-04-07
HPLC 纯度99.53%
内毒素（LAL）通过 · < 0.5 EU/mg
关于 Tesamorelin
Buy Tesamorelin 5mg at IGF1 Shop. Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone with a trans-3-hexenoyl moiety attached to the N-terminus, protecting against DPP-4 enzymatic degradation. This stabilization extends the half-life and the duration of GH release beyond what unmodified GHRH offers. Each Tesamorelin 5mg vial is HPLC-verified at ≥99% purity, ESI mass-spec confirmed, and accompanied by a per-lot Certificate of Analysis from an ISO 17025-accredited lab.
又称： Tesamorelin · TH9507 · Stabilized GHRH analog
Tesamorelin — 作用机制与规格
Tesamorelin is a synthetic 44-amino acid analog of human growth hormone-releasing hormone with a trans-3-hexenoyl moiety attached to the N-terminus, protecting against DPP-4 degradation. Currently out of stock — restock expected within 4 weeks.
质量与放行标准
Tesamorelin 的每批次仅在通过反相 HPLC（220 nm 下对照参考标准品面积纯度 ≥ 99%）、ESI 质谱分子量确认及鲎变形细胞溶解物（LAL）内毒素检测（低于 0.5 EU/mg）后才予以放行。批次专属分析证书随订单提供，购买前可按需索取。
$75
3 瓶 · $25/瓶
常见问题
Tesamorelin — 常见问题
What is Tesamorelin?
Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH 1-44) with a trans-3-hexenoyl group attached to the N-terminus. The hexenoyl modification protects against DPP-4 degradation, dramatically extending the peptide's half-life relative to native GHRH. CAS 218949-48-5.
How is Tesamorelin different from Sermorelin and CJC-1295?
Sermorelin is GHRH(1-29) — the shortest active GHRH fragment, with a very short half-life. CJC-1295 (No DAC) is a substituted GHRH(1-29) analog with four amino acid changes for stability. Tesamorelin is GHRH(1-44) — the full-length GHRH with N-terminal hexenoyl protection. Tesamorelin shows the longest duration of action of the three at clinical doses.
What is the standard Tesamorelin dose?
Common protocols use 1-2 mg per subcutaneous injection, once daily before bed. A 5mg vial reconstituted with 2mL bacteriostatic water yields 250 mcg per 0.1mL, so a 1mg dose equals 0.4mL (40 units on a U-100 insulin syringe). Cycle length typically runs 12-26 weeks with periodic breaks.
How is Tesamorelin tested?
Each Tesamorelin lot is HPLC-tested to ≥99% purity, confirmed by ESI mass spectrometry against the theoretical 5,135.85 Da molecular weight, and endotoxin-tested by LAL to <0.5 EU/mg. ISO 17025-accredited third-party labs perform the testing; the per-lot COA ships with your order.
How do I store Tesamorelin?
Lyophilized Tesamorelin is best stored at -20°C protected from light; it is stable refrigerated at 2-8°C for shorter periods. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within 14-21 days. Do not freeze the reconstituted solution.
